Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-25-000036
Filing Date
2025-05-01
Accepted
2025-05-01 10:26:14
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20250331.htm   iXBRL 10-Q 1152939
2 EX-31.1 exhibit31-1x03x31x25.htm EX-31.1 9699
3 EX-31.2 exhibit31-2x03x31x25.htm EX-31.2 9710
4 EX-32.1 exhibit32-1x03x31x25.htm EX-32.1 4693
5 EX-32.2 exhibit32-2x03x31x25.htm EX-32.2 4688
  Complete submission text file 0001439222-25-000036.txt   5813804

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20250331.xsd EX-101.SCH 41756
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20250331_cal.xml EX-101.CAL 69132
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20250331_def.xml EX-101.DEF 152149
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20250331_lab.xml EX-101.LAB 550062
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20250331_pre.xml EX-101.PRE 373336
74 EXTRACTED XBRL INSTANCE DOCUMENT agio-20250331_htm.xml XML 698849
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 25900288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)